Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2010

01-05-2010 | Original Article

Frequency and Risk Factors for Barrett’s Esophagus in Taiwanese Patients: A Prospective Study in a Tertiary Referral Center

Authors: Chia-Jung Kuo, Cheng-Hui Lin, Nai-Jen Liu, Ren-Chin Wu, Jui-Hsiang Tang, Chi-Liang Cheng

Published in: Digestive Diseases and Sciences | Issue 5/2010

Login to get access

Abstract

Background

There is a paucity of epidemiologic data concerning Barrett’s esophagus (BE) in Taiwan.

Aim

This study aimed to investigate the frequency of and risk factors for BE in self-referred Taiwanese patients undergoing diagnostic endoscopy.

Methods

A total of 736 consecutive patients undergoing upper endoscopy for a variety of gastro-intestinal symptoms from February to October 2007 were evaluated. A standard questionnaire was used to record the clinical characteristics and patient symptoms. Gastro-esophageal reflux disease (GERD) was diagnosed using the Montreal definition, while the Los Angeles Classification and Prague Circumferential and Maximal Criteria were used to assess erosive esophagitis and BE, respectively. Four-quadrant biopsies were taken from endoscopically suspected esophageal metaplastic mucosa every 2 cm for histologic evaluation. Eight variables were tested using a logistic regression model to identify risk factors for BE in GERD patients.

Results

GERD was diagnosed in 344 patients, with typical esophageal symptoms noted in 255, reflux chest pain syndrome in 107, and extra-esophageal syndrome in 51, while 27 were asymptomatic. The mean age of the GERD patients was 49.8 years and 55.5% of them were male. Thirty-six percent (123 of 344) demonstrated erosive esophagitis and 95% were classified as having Los Angeles grade A or B disease. BE was diagnosed in 13 patients (3.8% of GERD patients), three of whom had dysplastic mucosa. In the final analysis model, hiatal hernia (odds ratio [OR] = 4.7, 95% confidence interval [CI] = 1.3–17.7, P = 0.02) and GERD duration >5 years (OR = 4.2, 95% CI = 1.2–4.8, P = 0.03) were independent risk factors for the development of BE.

Conclusion

There is a 3.8% frequency of BE in Taiwanese GERD patients. Hiatal hernia and prolonged GERD duration are significant risk factors.
Literature
5.
go back to reference Sharma P, Morales TG, Sampliner RE. Short segment Barrett’s esophagus—the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998;93:1033–1036.PubMed Sharma P, Morales TG, Sampliner RE. Short segment Barrett’s esophagus—the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998;93:1033–1036.PubMed
6.
go back to reference Dekel R, Wakelin DE, Wendel C, et al. Progression or regression of Barrett’s esophagus—is it all in the eye of the beholder? Am J Gastroenterol. 2003;98:2612–2615.PubMed Dekel R, Wakelin DE, Wendel C, et al. Progression or regression of Barrett’s esophagus—is it all in the eye of the beholder? Am J Gastroenterol. 2003;98:2612–2615.PubMed
9.
go back to reference Locke GR, Talley NJ, Weaver AL, et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994;69:539–547.PubMed Locke GR, Talley NJ, Weaver AL, et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994;69:539–547.PubMed
10.
go back to reference Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180.CrossRefPubMed Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180.CrossRefPubMed
12.
go back to reference Azuma N, Endo T, Arimura Y, et al. Prevalence of Barrett’s esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett’s esophagus and esophageal adenocarcinoma in Japan. J Gastroenterol. 2000;35:583–592. doi:10.1007/s005350070057.CrossRefPubMed Azuma N, Endo T, Arimura Y, et al. Prevalence of Barrett’s esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett’s esophagus and esophageal adenocarcinoma in Japan. J Gastroenterol. 2000;35:583–592. doi:10.​1007/​s005350070057.CrossRefPubMed
16.
22.
go back to reference Lieberman DA, Oehlke M, Helfand M. Risk factors for Barrett’s esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol. 1997;92:1293–1297.PubMed Lieberman DA, Oehlke M, Helfand M. Risk factors for Barrett’s esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol. 1997;92:1293–1297.PubMed
26.
go back to reference Weston AP, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett’s esophagus, Barrett’s dysplasia, and Barrett’s adenocarcinoma. Am J Gastroenterol. 2000;95:387–394. doi:10.1111/j.1572-0241.2000.01758.x.CrossRefPubMed Weston AP, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett’s esophagus, Barrett’s dysplasia, and Barrett’s adenocarcinoma. Am J Gastroenterol. 2000;95:387–394. doi:10.​1111/​j.​1572-0241.​2000.​01758.​x.CrossRefPubMed
28.
go back to reference Bak YT, Jung GM, Yeon JE, et al. Validity of the specialized columnar epithelium as a diagnostic criterion of the short segment Barrett’s esophagus. Korean J Intern Med. 1998;13:99–103.PubMed Bak YT, Jung GM, Yeon JE, et al. Validity of the specialized columnar epithelium as a diagnostic criterion of the short segment Barrett’s esophagus. Korean J Intern Med. 1998;13:99–103.PubMed
29.
go back to reference Trudgill NJ, Suvarna SK, Kapur KC, et al. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut. 1997;41:585–589.PubMedCrossRef Trudgill NJ, Suvarna SK, Kapur KC, et al. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut. 1997;41:585–589.PubMedCrossRef
Metadata
Title
Frequency and Risk Factors for Barrett’s Esophagus in Taiwanese Patients: A Prospective Study in a Tertiary Referral Center
Authors
Chia-Jung Kuo
Cheng-Hui Lin
Nai-Jen Liu
Ren-Chin Wu
Jui-Hsiang Tang
Chi-Liang Cheng
Publication date
01-05-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-0872-7

Other articles of this Issue 5/2010

Digestive Diseases and Sciences 5/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.